Literature DB >> 10854219

Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.

M Mercader1, B Taddeo, J R Panella, B Chandran, B J Nickoloff, K E Foreman.   

Abstract

Human herpesvirus 8 (HHV-8) is a gamma2-herpesvirus consistently identified in Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's disease. Although HHV-8 infection appears to be necessary, it may not be sufficient for development of KS without the involvement of other cofactors. One potentially important cofactor is HIV-1. HIV-1-infected cells produce HIV-1-related proteins and cytokines, both of which have been shown to promote growth of KS cells in vitro. Though HIV-1 is not absolutely necessary for KS development, KS is the most frequent neoplasm in AIDS patients, and AIDS-KS is recognized as a particularly aggressive form of the disease. To determine whether HIV-1 could participate in the pathogenesis of KS by modulating HHV-8 replication (rather than by inducing immunodeficiency), HIV-1-infected T cells were cocultured with the HHV-8-infected cell line, BCBL-1. The results demonstrate soluble factors produced by or in response to HIV-1-infected T cells induced HHV-8 replication, as determined by production of lytic phase mRNA transcripts, viral proteins, and detection of progeny virions. By focusing on cytokines produced in the coculture system, several cytokines known to be important in growth and proliferation of KS cells in vitro, particularly Oncostatin M, hepatocyte growth factor/scatter factor, and interferon-gamma, were found to induce HHV-8 lytic replication when added individually to BCBL-1 cells. These results suggest specific cytokines can play an important role in the initiation and progression of KS through reactivation of HHV-8. Thus, HIV-1 may participate more directly than previously recognized in KS by promoting HHV-8 replication and, hence, increasing local HHV-8 viral load.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854219      PMCID: PMC1850066          DOI: 10.1016/S0002-9440(10)65069-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.

Authors:  J P Zoeteweij; S T Eyes; J M Orenstein; T Kawamura; L Wu; B Chandran; B Forghani; A Blauvelt
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Antibodies against human herpesvirus 8 in black South African patients with cancer.

Authors:  F Sitas; H Carrara; V Beral; R Newton; G Reeves; D Bull; U Jentsch; R Pacella-Norman; D Bourboulia; D Whitby; C Boshoff; R Weiss
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

3.  Utilizing uracil DNA glycosylase to control carryover contamination in PCR: characterization of residual UDG activity following thermal cycling.

Authors:  C G Thornton; J L Hartley; A Rashtchian
Journal:  Biotechniques       Date:  1992-08       Impact factor: 1.993

Review 4.  Clinical aspects of Kaposi's sarcoma.

Authors:  A Buchbinder; A E Friedman-Kien
Journal:  Curr Opin Oncol       Date:  1992-10       Impact factor: 3.645

5.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.

Authors:  P Monini; S Colombini; M Stürzl; D Goletti; A Cafaro; C Sgadari; S Buttò; M Franco; P Leone; S Fais; P Leone; G Melucci-Vigo; C Chiozzini; F Carlini; G Ascherl; E Cornali; C Zietz; E Ramazzotti; F Ensoli; M Andreoni; P Pezzotti; G Rezza; R Yarchoan; R C Gallo; B Ensoli
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

6.  Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies.

Authors:  L Zhu; V Puri; B Chandran
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

7.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Human B cell lines express the interferon gamma gene.

Authors:  M A Dayton; T J Knobloch; D Benjamin
Journal:  Cytokine       Date:  1992-11       Impact factor: 3.861

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  50 in total

1.  An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors:  Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

2.  Preparation and characterization of polyclonal antibody against Kaposi's sarcoma-associated herpesvirus lytic gene encoding RTA.

Authors:  Weifei Fan; Qiao Tang; Chenyou Shen; Di Qin; Chun Lu; Qin Yan
Journal:  Folia Microbiol (Praha)       Date:  2015-04-02       Impact factor: 2.099

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.

Authors:  S Sakakibara; K Ueda; J Chen; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Adetola Olalekan Ajibade; Fengchun Ye; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2007-10-26       Impact factor: 3.616

6.  Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins.

Authors:  Ossie F Dyson; Telisha L Oxendine; Khalief E Hamden; Patrick W Ford; Shaw M Akula
Journal:  Cell Microbiol       Date:  2008-03-25       Impact factor: 3.715

Review 7.  HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis.

Authors:  Eliane Rohner; Natascha Wyss; Zina Heg; Zully Faralli; Sam M Mbulaiteye; Urban Novak; Marcel Zwahlen; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2015-07-28       Impact factor: 7.396

8.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.

Authors:  Mhairi Maskew; A Patrick MacPhail; Denise Whitby; Matthias Egger; Matthew P Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

10.  HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.

Authors:  Qin Yan; Chenyou Shen; Jie Qin; Wan Li; Minmin Hu; Hongmei Lu; Di Qin; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.